Medicover
Noleen McCloskey currently serves as a Board Member at NIPD Genetics and has held various senior roles at Medicover since September 2010, including Divisional HR Director for Diagnostic Services and Group Development & Talent Director. Noleen has global responsibility for leadership and talent development across Medicover, overseeing strategic elements of development and working in collaboration with senior executives and external partners. Previous experience includes roles as Group HR Director at Fleet Logistics International and Business Transformation Program Manager at Honeywell Building Solutions EMEAI. Noleen holds multiple educational credentials, including an Executive Programme for Women Leaders from Vlerick Business School and a Bachelor of Science in International Hotel & Business Management from Shannon College of Hotel Management.
This person is not in any teams
This person is not in any offices
Medicover
2 followers
Medicover is a leading international healthcare and diagnostic services provider headquartered in Sweden and listed on Nasdaq Stockholm. Established in 1995 in response to the growing demand for high-quality healthcare services in Poland, Medicover subsequently expanded to other countries, fulfilling similar needs. Today, Medicover’s largest operations are in Poland, Germany, Romania Ukraine and India. Medicover provides a broad spectrum of healthcare services via an extensive network of ambulatory clinics, hospitals, speciality-care facilities laboratories and blood-drawing points through two divisions – Healthcare Services and Diagnostic Services. Healthcare Services – offers high-quality care based on its Integrated Healthcare Model and a broad offering of speciality-care services with a focus on health and wellbeing. Services are offered in 180 medical clinics, 40 hospitals, 50 pharmacies, 113 dental clinics, 30 fertility clinics, 16 mental health centres and 1 psychiatric hospital, 133 gyms and 40 optic salons. The major markets are Poland, India and Romania. Diagnostic Services – offers a broad range of clinical laboratory services including a broad range of laboratory tests in all major clinical pathology areas, ranging from routine to advanced tests and from prevention to monitoring of treatments. The business is conducted through a network of 118 laboratories, 892 blood-drawing points and 27 clinics in ten countries. The major markets are Germany, Romania, Ukraine and Poland. For more information, visit www.medicover.com